Caris Life Sciences, Inc. engages in the provision of biotechnology solutions. It specializes in pathology, molecular profiling, and microvesicle technology for the diagnosis and treatment of cancerous tissues. The company was founded by David D. Halbert in 2008 and is headquartered in Phoenix, AZ.

SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.

EpiCypher develops and manufactures novel products and tools for epigenetics and chromatin biology research. Our team and founders include renowned chromatin researchers, whose expertise and unique insight into epigenetics and chromatin biology benefit our customers in ways that other companies cannot duplicate.

BGI Shenzhen Co., Ltd. engages in the equity investment and asset management. Its business scope includes research and development and sales of computer hardware and software and peripheral equipment technology; import and export of goods and technology; equity investment; investment in industrial development; and aquatic product farming and sales. The company was founded on August 21, 2008 and is headquartered in Shenzhen, China.

Diagnodus Ltd. is a British private company. The firm provides medical diagnostics services.

Cornell provides education about the earth and atmospheric sciences. They offer summer and winter sessions. Their students contact them through phone and email services.

NIBEC Co., Ltd. engages in the development, manufacture, and commercialization of medical products and supplies. Its business areas include oral care products, bio materials for tissue regeneration, cosmetics and bio fusion peptide businesses. The Oral Care Products business offers tooth whitening, tooth desensitizer and dental conditioner. The Bio materials for Tissue Regeneration business offers bone graft materials, barrier, intra oral, resorbable collagen membrane matrix and growth-factor enhanced matrix. The Bio Fusion Peptide business provides bone graft material, biodegradable collagen matrix and synthetic bone graft material. The company was founded on February 20, 2004 and is headquartered in Jincheon-gun, South Korea.

Genervon is a clinical-stage biopharmaceutical company focused on novel treatments for neurodegenerative diseases and disorders.

Anaxomics Biotech SL discovers and develops pharmaceutical products. Its products and services include discovery and preclinical development, academic research centers, solutions for VCs and investors, clinical development, nutraceutical and cosmetics, and SIMScells. The company was founded by Jose Manuel Mas and Jordi Naval in 2007 and is headquartered in Barcelona, Spain.

Operates as an non-classified establishment

LSI Medience Corp. engages in the clinical examination business. It also engages in the diagnostic agent and drug discovery support business. The company was founded on April 1, 2014 and is headquartered in Tokyo, Japan.

The Istituto Superiore di Sanità (Italian National Institute of Health), also ISS, is an Italian public institution that, as the leading technical-scientific body of the Italian National Health Service (Servizio Sanitario Nazionale), performs research, trials, control, counseling, documentation and training for public health. The Institute is under the supervision of the Ministero della Salute (Ministry of Health).

Linkagene is a private equity firm headquartered in San Diego, California

InterVenn is a life science company unlocking the value of glycoproteomics—glycosylated proteins which are responsible for driving protein function—for the development of transformational healthcare solutions. The glycoproteome is a source of life-critical information about human biology that has the potential to improve patient outcomes significantly. Still, it has remained inaccessible due to its vast complexity. InterVenn has pioneered a first-of-its-kind AI-powered platform to decode this layer of biology at a clinically meaningful scale for the first time in history. The company’s platform can produce a robust pipeline of powerful clinical applications, ranging from early disease screening to diagnostics and, potentially, therapeutics. Its proprietary technology platform is accessible to pharma partners seeking rich biology insights to propel their research and development efforts. Founded by Nobel Laureate Dr. Carolyn Bertozzi, world-class scientist and distinguished professor Dr. Carlito Lebrilla and leading AI/ML expert & serial entrepreneur Aldo Carrascoso, InterVenn will contribute to making the new era of personalized, predictive, and preventative care a reality. For more information about InterVenn, visit www.intervenn.com.

Liangzhun (Shanghai) Industrial Co., Ltd., established on 2016-12-28, Business scope includes licensed projects:Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:working in medical technology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology),Internet of things technology,Biological Technology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology)Technology development in the field,technical consulting,Technical Services,electronic product,one type,Class II medical device,Green facilities,computer,Software and auxiliary equipment sales,Computer software development and maintenance,Nutrition and Health Consulting Services(except for medical diagnosis),Contract Energy Management Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

The only continuous passive health monitoring device that works at home and doesn't require any user behavior change. Our device hangs on your toilet to automatically test urine from flush water to generate lab quality results for many health and diet indicators. We believe combining AI with 1000s of personalized biomarkers collected day after day, week after week, month after month, and year after year will become increasingly powerful in the prediction of health conditions and objective personalized prevention as our user base grows. Funded by the National Science Foundation and National Institutes of Health.

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.